Freya Van Houtte

483 total citations
21 papers, 380 citations indexed

About

Freya Van Houtte is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Freya Van Houtte has authored 21 papers receiving a total of 380 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 15 papers in Hepatology and 7 papers in Immunology. Recurrent topics in Freya Van Houtte's work include Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (12 papers) and Viral gastroenteritis research and epidemiology (6 papers). Freya Van Houtte is often cited by papers focused on Hepatitis B Virus Studies (17 papers), Hepatitis C virus research (12 papers) and Viral gastroenteritis research and epidemiology (6 papers). Freya Van Houtte collaborates with scholars based in Belgium, France and United Kingdom. Freya Van Houtte's co-authors include Geert Leroux‐Roels, Peter Vanlandschoot, Benedikte Serruys, Ali Farhoudi, Philip Meuleman, Phebe Verbrugghe, Lieven Verhoye, Isabelle Desombere, Arvind H. Patel and Thomas F. Baumert and has published in prestigious journals such as Hepatology, Gut and Biochemical and Biophysical Research Communications.

In The Last Decade

Freya Van Houtte

20 papers receiving 371 citations

Peers

Countries citing papers authored by Freya Van Houtte

Since Specialization

Citations

This map shows the geographic impact of Freya Van Houtte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Freya Van Houtte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Freya Van Houtte more than expected).

Fields of papers citing papers by Freya Van Houtte

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Freya Van Houtte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Freya Van Houtte. The network helps show where Freya Van Houtte may publish in the future.

Co-authorship network of co-authors of Freya Van Houtte

This figure shows the co-authorship network connecting the top 25 collaborators of Freya Van Houtte. A scholar is included among the top collaborators of Freya Van Houtte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Freya Van Houtte. Freya Van Houtte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Higher Hepatitis E Seroprevalence in Workers in the Pig Sector in Flanders, Belgium: Results From a Seroprevalence Case‐Control Study 2025 ·Zoonoses and Public Health ·Heidi Janssens, (unknown), Stijn Jonckheere, Freya Van Houtte, Philip Meuleman, Tom Geens	1
2	The phosphatidylserine receptor TIM1 promotes infection of enveloped hepatitis E virus 2023 ·Cellular and Molecular Life Sciences ·(unknown), Irma Lemmens, (unknown), (unknown), Karin Weening, Freya Van Houtte, Xavier Hanoulle, Laurence Cocquerel, Ali Amara, Jan Tavernier, Philip Meuleman	12
3	Virus–Host Protein Interaction Network of the Hepatitis E Virus ORF2-4 by Mammalian Two-Hybrid Assays 2023 ·Viruses ·(unknown), Irma Lemmens, Karin Weening, (unknown), Freya Van Houtte, Jan Tavernier, Philip Meuleman	0
4	Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections 2022 ·Gut ·(unknown), (unknown), Gustaf Ahlén, Sandra Ciesek, (unknown), Anna Pasetto, Stephan Urban, Freya Van Houtte, Lieven Verhoye, Heiner Wedemeyer, Magnus Johansson, Lars Frelin, Matti Sällberg, Philip Meuleman	7
5	A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection 2022 ·JHEP Reports ·(unknown), Freya Van Houtte, Lieven Verhoye, Ahmed Atef Mesalam, Sandra Ciesek, Philippe Roingeard, Heiner Wedemeyer, Geert Leroux‐Roels, Philip Meuleman	6
6	A Role for B Cells to Transmit Hepatitis C Virus Infection 2021 ·Frontiers in Immunology ·Isabelle Desombere, Freya Van Houtte, Ali Farhoudi, Lieven Verhoye, (unknown), (unknown), (unknown), (unknown), Hans Van Vlierberghe, A Elewaut, Andrea Magrì, Zania Stamataki, Philip Meuleman, Jane A. McKeating, Geert Leroux‐Roels	5
7	Hepatitis E virus prevalence in Flemish blood donors 2019 ·Journal of Viral Hepatitis ·(unknown), Freya Van Houtte, Lieven Verhoye, (unknown), (unknown), Veerle Compernolle, Philip Meuleman	12
8	A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo 2017 ·Antiviral Research ·Isabelle Desombere, Ahmed Atef Mesalam, Richard A. Urbanowicz, Freya Van Houtte, Lieven Verhoye, Zhen–Yong Keck, Ali Farhoudi, Koen Vercauteren, Karin Weening, Thomas F. Baumert, Arvind H. Patel, Steven K. H. Foung, Jonathan Ball, Geert Leroux‐Roels, Philip Meuleman	20
9	Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1 2017 ·Virology ·Ahmed Atef Mesalam, Isabelle Desombere, Ali Farhoudi, Freya Van Houtte, Lieven Verhoye, Jonathan K. Ball, Jean Dubuisson, Steven K. H. Foung, Arvind H. Patel, Mats A. A. Persson, Geert Leroux‐Roels, Philip Meuleman	8
10	Monoclonal anti‐envelope antibody AP33 protects humanized mice against a patient‐derived hepatitis C virus challenge 2015 ·Hepatology ·Isabelle Desombere, Samira Fafi‐Kremer, Freya Van Houtte, Patrick Pessaux, Ali Farhoudi, Laura Heydmann, Lieven Verhoye, Sarah Cole, Jane A. McKeating, Geert Leroux‐Roels, Thomas F. Baumert, Arvind H. Patel, Philip Meuleman	32
11	Production, characterization and in vitro testing of HBcAg-specific VHH intrabodies 2009 ·Journal of General Virology ·Benedikte Serruys, Freya Van Houtte, (unknown), Geert Leroux‐Roels, Peter Vanlandschoot	33
12	Llama‐derived single‐domain intrabodies inhibit secretion of hepatitis B virions in mice† 2008 ·Hepatology ·Benedikte Serruys, Freya Van Houtte, Phebe Verbrugghe, Geert Leroux‐Roels, Peter Vanlandschoot	46
13	Human hepatocytes secrete soluble CD14, a process not directly influenced by HBV and HCV infection 2005 ·Clinica Chimica Acta ·Philip Meuleman, Sophia Steyaert, Louis Libbrecht, (unknown), Freya Van Houtte, (unknown), Bernard de Hemptinne, Tania Roskams, Peter Vanlandschoot, Geert Leroux‐Roels	28
14	Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked 2005 ·Journal of General Virology ·Peter Vanlandschoot, Freya Van Houtte, Peter Ulrichts, Jan Tavernier, Geert Leroux‐Roels	15
15	The arginine-rich carboxy-terminal domain of the hepatitis B virus core protein mediates attachment of nucleocapsids to cell-surface-expressed heparan sulfate 2004 ·Journal of General Virology ·Peter Vanlandschoot, Freya Van Houtte, Benedikte Serruys, Geert Leroux‐Roels	32
16	A temperature-dependent inhibitory activity of serum on the capacity of Saccharomyces cerevisiae-derived hepatitis B surface antigen to bind to monocytes 2004 ·Archives of Virology ·Peter Vanlandschoot, Freya Van Houtte, (unknown), Felix Stelter, Francisco Gavilanes, Geert Leroux‐Roels	1
17	Saccharomyces cerevisiae‐derived HBsAg preparations differ in their attachment to monocytes, immune‐suppressive potential, and T‐cell immunogenicity 2003 ·Journal of Medical Virology ·Peter Vanlandschoot, Freya Van Houtte, Frans J. Hoek, Rienk Nieuwland, Geert Leroux–Roels	14
18	Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes 2002 ·Biochemical and Biophysical Research Communications ·Peter Vanlandschoot, (unknown), Freya Van Houtte, Geert Leroux‐Roels	26
19	Hepatitis B virus surface antigen suppresses the activation of monocytes through interaction with a serum protein and a monocyte-specific receptor 2002 ·Journal of General Virology ·Peter Vanlandschoot, Freya Van Houtte, (unknown), Ali Farhoudi, Geert Leroux‐Roels	43
20	LPS-binding protein and CD14-dependent attachment of hepatitis B surface antigen to monocytes is determined by the phospholipid moiety of the particles 2002 ·Journal of General Virology ·Peter Vanlandschoot, Freya Van Houtte, (unknown), Ali Farhoudi, Felix Stelter, D L Peterson, Julián Gómez‐Gutiérrez, Francisco Gavilanes, Geert Leroux‐Roels	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact